Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rongbin Zhou

Showing results (61-70 of 112) with videos related to

Pageof 12
Sort By:
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|July 29, 2025
An interpretable machine learning model for preoperative prediction of renal mass malignancyZuheng Wang, Xing He, Hanyang Ou, et al.
Cell Death & Disease|April 4, 2025
A small molecule directly targets NLRP3 to promote inflammasome activation and antitumor immunityXuemei Liu, Hongbin He, Minghui Qi, et al.
The FEBS Journal|April 4, 2019
Crystal structure and activation mechanism of DR3 death domainXueying Yin, Wenqian Li, Huan Ma, et al.
Carcinogenesis|April 19, 2014
Endothelial cell-derived fibronectin extra domain A promotes colorectal cancer metastasis via inducing epithelial-mesenchymal transitionJuanjuan Ou, Yuan Peng, Jia Deng, et al.
Immunity|July 2, 2013
Omega-3 fatty acids prevent inflammation and metabolic disorder through inhibition of NLRP3 inflammasome activationYiqing Yan, Wei Jiang, Thibaud Spinetti, et al.
Nature Communications|August 6, 2017
CLICs-dependent chloride efflux is an essential and proximal upstream event for NLRP3 inflammasome activationTiantian Tang, Xueting Lang, Congfei Xu, et al.
EMBO Molecular Medicine|March 14, 2018
Tranilast directly targets NLRP3 to treat inflammasome-driven diseasesYi Huang, Hua Jiang, Yun Chen, et al.
Nature Communications|July 1, 2018
Oridonin is a covalent NLRP3 inhibitor with strong anti-inflammasome activityHongbin He, Hua Jiang, Yun Chen, et al.
Journal of Hepatology|January 14, 2015
Invariant NKT cells promote alcohol-induced steatohepatitis through interleukin-1β in miceKele Cui, Guoxiu Yan, Congfei Xu, et al.
Nature Immunology|October 2, 2024
GPR34 is a metabolic immune checkpoint for ILC1-mediated antitumor immunityJiaxian Yan, Chi Zhang, Yueli Xu, et al.
Pageof 12

Showing results (61-70 of 112) with videos related to

Sort By:
Pageof 12
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|July 29, 2025
An interpretable machine learning model for preoperative prediction of renal mass malignancyZuheng Wang, Xing He, Hanyang Ou, et al.
Cell Death & Disease|April 4, 2025
A small molecule directly targets NLRP3 to promote inflammasome activation and antitumor immunityXuemei Liu, Hongbin He, Minghui Qi, et al.
The FEBS Journal|April 4, 2019
Crystal structure and activation mechanism of DR3 death domainXueying Yin, Wenqian Li, Huan Ma, et al.
Carcinogenesis|April 19, 2014
Endothelial cell-derived fibronectin extra domain A promotes colorectal cancer metastasis via inducing epithelial-mesenchymal transitionJuanjuan Ou, Yuan Peng, Jia Deng, et al.
Immunity|July 2, 2013
Omega-3 fatty acids prevent inflammation and metabolic disorder through inhibition of NLRP3 inflammasome activationYiqing Yan, Wei Jiang, Thibaud Spinetti, et al.
Nature Communications|August 6, 2017
CLICs-dependent chloride efflux is an essential and proximal upstream event for NLRP3 inflammasome activationTiantian Tang, Xueting Lang, Congfei Xu, et al.
EMBO Molecular Medicine|March 14, 2018
Tranilast directly targets NLRP3 to treat inflammasome-driven diseasesYi Huang, Hua Jiang, Yun Chen, et al.
Nature Communications|July 1, 2018
Oridonin is a covalent NLRP3 inhibitor with strong anti-inflammasome activityHongbin He, Hua Jiang, Yun Chen, et al.
Journal of Hepatology|January 14, 2015
Invariant NKT cells promote alcohol-induced steatohepatitis through interleukin-1β in miceKele Cui, Guoxiu Yan, Congfei Xu, et al.
Nature Immunology|October 2, 2024
GPR34 is a metabolic immune checkpoint for ILC1-mediated antitumor immunityJiaxian Yan, Chi Zhang, Yueli Xu, et al.
Pageof 12